Aleks Guvenel

Aleks Guvenel, PhD, is an expert in immunology and process development with extensive experience in the biopharmaceutical sector. Currently serving as Associate Director and Principal Scientist of Process Development at Quell Therapeutics since December 2020, Aleks leads the Cell Process Development team focusing on the CAR-Treg platform and manages both projects and collaborations. Prior to this role, Aleks was a Senior Cell Processing Scientist at Quell Therapeutics, finalizing large-scale process development for clinical trials. Aleks has previously held the position of Lead Scientist for Phase I/II clinical trials at UCL, where the focus was on the production of gene-modified T cells in cGMP settings. Academic training includes a PhD in Immunology, along with Master's and Bachelor's degrees from Imperial College London and King's College London, respectively. Additionally, experience at Glaxo Smith Kline as a Research Scientist involved projects related to vaccine immunology during an industrial placement.